🔎 Trials Near Me

Hem › Metastaserande cancer › Ohio › Columbus

Kliniska studier för Metastaserande cancer i Columbus, OH

27 studier för Metastaserande cancer söker deltagare vid platser i och runt Columbus (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RekryterarFas 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • och 13 fler
Alla åldrar · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

RekryterarFas 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT05372614

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

RekryterarFas 1
  • ALX Center 10, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07085091

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

RekryterarFas 2/3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT06943755

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

RekryterarFas 1/2
  • Ohio State University, Columbus
Ålder 12 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT05118789

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RekryterarFas 3
  • The Mark H Zangmeister Center, Columbus
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Hilliard · 10 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213804

SLV-154 Treatment of Advanced Cancers

RekryterarFas 1
  • The James Outpatient Care West Center, Columbus
Ålder 12 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06771219

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

RekryterarFas 3
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

RekryterarFas 3
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07174336

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

RekryterarFas 1/2
  • Clinical Study Site, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 10 sep. 2026 · NCT07335497

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

RekryterarFas 1
  • Ohio State University Hospital, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06561685

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekryterarFas 3
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06119581

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

RekryterarFas 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT06311214

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

RekryterarFas 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 24 aug. 2026 · NCT05687136

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

RekryterarFas 2
  • Ohio State University, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 21 aug. 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

RekryterarFas 1
  • The Ohio State University (OSU), Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT05614739

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

RekryterarFas 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 3 aug. 2026 · NCT05687110

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RekryterarFas 3
  • Research Site, Columbus
  • Research Site, Hilliard · 10 mi bort
Ålder 18 och äldre · Kvinnor · Uppdaterad 29 juli 2026 · NCT07044336

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

RekryterarFas 1
  • The Ohio State University Comprehensive Cancer Center, Columbus
Ålder 18 och äldre · Män · Uppdaterad 9 juli 2026 · NCT07103018

A Study of LY4175408 in Participants With Advanced Cancer

RekryterarFas 1
  • The Ohio State University (OSU) Wexner Medical Center, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 23 juni 2026 · NCT07046923

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

RekryterarFas 1/2
  • OSU Brain & Spine Hospital, Columbus
Ålder 12 och äldre · Alla kön · Uppdaterad 27 maj 2026 · NCT05384626

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

RekryterarFas 3
  • Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 18 maj 2026 · NCT06757634

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

RekryterarFas 3
  • Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 9 apr. 2026 · NCT06064877

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

RekryterarFas 1
  • OSU Brain and Spine Hospital, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 25 feb. 2026 · NCT06521554

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

RekryterarFas 3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Ålder 18 och äldre · Alla kön · Uppdaterad 6 feb. 2026 · NCT06127407

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekryterarObservationsstudie
  • Massive Bio SYNERGY-AI site, Columbus
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

Metastaserande cancer-studier i andra städer

Andra studier i Columbus

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.